These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38531835)

  • 1. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
    Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia.
    Ohi K; Takai K; Sugiyama S; Kitagawa H; Kataoka Y; Soda M; Kitaichi K; Kawasaki Y; Ito M; Shioiri T
    CNS Spectr; 2021 Mar; ():1-7. PubMed ID: 33731244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
    Li Z; Li D; Chen X
    J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.
    Steen NE; Methlie P; Lorentzen S; Dieset I; Aas M; Nerhus M; Haram M; Agartz I; Melle I; Berg JP; Andreassen OA
    J Psychiatr Res; 2014 May; 52():57-62. PubMed ID: 24534618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.
    Shin D; Lee J; Kim Y; Park J; Shin D; Song Y; Joo EJ; Roh S; Lee KY; Oh S; Ahn YM; Rhee SJ; Kim Y
    J Proteome Res; 2024 Jan; 23(1):329-343. PubMed ID: 38063806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome.
    Cheng S; Guan F; Ma M; Zhang L; Cheng B; Qi X; Liang C; Li P; Kafle OP; Wen Y; Zhang F
    Eur Psychiatry; 2020 Feb; 63(1):e17. PubMed ID: 32093803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
    Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
    World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transdiagnostic comparison of affective decision-making in patients with schizophrenia, major depressive disorder, or bipolar disorder.
    Gu YT; Zhou C; Yang J; Zhang Q; Zhu GH; Sun L; Ge MH; Wang YY
    Psych J; 2020 Apr; 9(2):199-209. PubMed ID: 32077267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of major depression, schizophrenia and bipolar disorder with thyroid cancer: a bidirectional two-sample mendelian randomized study.
    Qiu R; Lin H; Jiang H; Shen J; He J; Fu J
    BMC Psychiatry; 2024 Apr; 24(1):261. PubMed ID: 38594691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
    Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
    Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder.
    Prasannakumar A; Kumar V; Mailankody P; Appaji A; Battu R; Berendschot TTJM; Rao NP
    World J Biol Psychiatry; 2023 Oct; 24(8):707-720. PubMed ID: 37070475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Inflammatory Marker Abnormalities in Major Psychiatric Diseases: a Systematic Review of Postmortem Brain Studies.
    Ai YW; Du Y; Chen L; Liu SH; Liu QS; Cheng Y
    Mol Neurobiol; 2023 Apr; 60(4):2116-2134. PubMed ID: 36600081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders.
    Miyamoto K; Funahashi Y; Yoshino Y; Kawabe K; Yamazaki K; Ozaki Y; Mori Y; Ochi S; Iga JI; Ueno SI
    Asian J Psychiatr; 2020 Aug; 52():102112. PubMed ID: 32371365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
    Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
    J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders.
    Yang J; Yan B; Zhao B; Fan Y; He X; Yang L; Ma Q; Zheng J; Wang W; Bai L; Zhu F; Ma X
    Schizophr Bull; 2020 Jul; 46(4):804-813. PubMed ID: 31919502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.